daunorubicin has been researched along with sphingosine 1-phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Checa, JC; García-Ruiz, C; Llacuna, L; Morales, A; París, R; Villanueva, A | 1 |
| Banno, Y; Furuhata, A; Gao, S; Ito, H; Ito, Y; Kimura, A; Kojima, T; Murakami, M; Murate, T; Nakamura, M; Nemoto, S; Nozawa, Y; Sobue, S; Suzuki, M; Takagi, A | 1 |
2 other study(ies) available for daunorubicin and sphingosine 1-phosphate
| Article | Year |
|---|---|
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.
Topics: Animals; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Daunorubicin; Drug Therapy; Endocannabinoids; Ethanolamines; Galactosylgalactosylglucosylceramidase; Humans; Lysophospholipids; Mice; Microscopy, Electron, Transmission; Mitochondria; Oleic Acids; Protease Inhibitors; RNA, Messenger; RNA, Small Interfering; Sphingosine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |
Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.
Topics: Antibiotics, Antineoplastic; Biomarkers; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Leukemia; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Sphingosine | 2008 |